News

From "Price Battle" to "Value Reconstruction": The 12th Batch of National Drug Procurement from the Perspective of Intelligent High end Equipment

When the 12th batch of national drug procurement came to an end with "327 companies and 521 products selected", the outside world focused more on price reductions and the list of companies. From the perspective of intelligent high-end equipment, this is not a simple "price war", but a landmark event in the evolution of China's pharmaceutical supply chain towards a modern industrial system driven by data, precise regulation, and quality priority. The precision manufacturing capability and digital control system represented by intelligent equipment are becoming the implicit "technical sieve" behind the centralized procurement rules.

Aug 05,2026

Only one company has released its Environmental, Social, and Governance (ESG) report for the year 2025

On July 30, 2026, only one company officially released its Environmental, Social, and Governance (ESG) report for the year 2025. This is the first sustainability report released by the company to industry partners and the general public, which systematically presents the company's annual practices and achievements in green intelligent manufacturing, industry collaboration, organizational governance, and other areas.

Aug 18,2026

China Non Prescription Drug Association visits Yuyue Medical and only one company

At Yuyue Medical, President Liu Pei and his delegation visited the company's intelligent manufacturing production line and product display center to understand the company's technological innovation and market layout in areas such as respiratory therapy

Mar 16,2026

Intelligent equipment leads the upgrading of traditional Chinese medicine industry: precise and efficient, intelligent manufacturing for the future

Jan 20,2026

< 1 >